论文期刊

取消

高级检索

检索历史清除

首页> BMC pulmonary medicine> Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study.

Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study.

导出 OA

翻译打印收藏纠错

作者： Yuzo,Suzuki ^[1] ; Kazutaka,Mori ^[2] ; Yuya,Aono ^[3] ; Masato,Kono ^[4] ; Hirotsugu,Hasegawa ^[5] ; Koshi,Yokomura ^[5] ; Hyogo,Naoi ^[3] ; Hironao,Hozumi ^[3] ; Masato,Karayama ^[3] ; Kazuki,Furuhashi ^[3] ; Noriyuki,Enomoto ^[3] ; Tomoyuki,Fujisawa ^[3] ; Yutaro,Nakamura ^[3] ; Naoki,Inui ^[3] ; Hidenori,Nakamura ^[4] ; Takafumi,Suda ^[3]

作者单位： Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan. yuzosuzu@hama-med.ac.jp. ^[1] Department of Respiratory Medicine, Shizuoka City Shimizu Hospital, Hamamatsu, Japan. ^[2] Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan. ^[3] Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan. ^[4] Department of Respiratory Medicine, Seirei Mikatahara General Hospital, Hamamatsu, Japan. ^[5]

关键词 Antifibrotic therapy Idiopathic pulmonary fibrosis Switch of antifibrotics

主题词老年人(Aged);疾病恶化(Disease Progression);用药计划表(Drug Administration Schedule);药物替代(Drug Substitution);女(雌)性(Female);人类(Humans);特发性肺纤维化(Idiopathic Pulmonary Fibrosis);吲哚类(Indoles);日本(Japan);男(雄)性(Male);预后(Prognosis);倾向性评分(Propensity Score);吡啶酮类(Pyridones);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome);肺活量(Vital Capacity)

DOI 10.1186/s12890-021-01587-3

PMID 34247593

发布时间 2024-08-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

BMC pulmonary medicine

BMC pulmonary medicine

2021年21卷1期

221页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷